Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bailey

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Developmental Cell|April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cellsValeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Journal of Medicinal Chemistry|March 23, 2016
Correction to Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-RegulatorsSébastien L Degorce, Andrew Bailey, Rowena Callis, et al.
Journal of Medicinal Chemistry|March 20, 2015
Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-RegulatorsSébastien L Degorce, Andrew Bailey, Rowena Callis, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Anticancer Research|February 4, 2019
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA TrialAmir Sonnenblick, Andrew Bailey, Beatrice Uziely, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
The International Journal of Behavioral Nutrition and Physical Activity|October 24, 2021
Scale-up of the Physical Activity 4 Everyone (PA4E1) intervention in secondary schools: 24-month implementation and cost outcomes from a cluster randomised controlled trialRachel Sutherland, Elizabeth Campbell, Matthew McLaughlin, et al.
The International Journal of Behavioral Nutrition and Physical Activity|August 11, 2020
Scale-up of the Physical Activity 4 Everyone (PA4E1) intervention in secondary schools: 12-month implementation outcomes from a cluster randomized controlled trialRachel Sutherland, Elizabeth Campbell, Matthew McLaughlin, et al.
BMC Public Health|November 14, 2019
Protocol for an effectiveness- implementation hybrid trial to assess the effectiveness and cost-effectiveness of an m-health intervention to decrease the consumption of discretionary foods packed in school lunchboxes: the 'SWAP IT' trialRachel Sutherland, Alison Brown, Nicole Nathan, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Developmental Cell|April 21, 2023
Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cellsValeria Amodeo, Timothy Davies, Amalia Martinez-Segura, et al.
Journal of Medicinal Chemistry|March 23, 2016
Correction to Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-RegulatorsSébastien L Degorce, Andrew Bailey, Rowena Callis, et al.
Journal of Medicinal Chemistry|March 20, 2015
Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-RegulatorsSébastien L Degorce, Andrew Bailey, Rowena Callis, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Anticancer Research|February 4, 2019
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA TrialAmir Sonnenblick, Andrew Bailey, Beatrice Uziely, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of ActionMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
The International Journal of Behavioral Nutrition and Physical Activity|October 24, 2021
Scale-up of the Physical Activity 4 Everyone (PA4E1) intervention in secondary schools: 24-month implementation and cost outcomes from a cluster randomised controlled trialRachel Sutherland, Elizabeth Campbell, Matthew McLaughlin, et al.
The International Journal of Behavioral Nutrition and Physical Activity|August 11, 2020
Scale-up of the Physical Activity 4 Everyone (PA4E1) intervention in secondary schools: 12-month implementation outcomes from a cluster randomized controlled trialRachel Sutherland, Elizabeth Campbell, Matthew McLaughlin, et al.
BMC Public Health|November 14, 2019
Protocol for an effectiveness- implementation hybrid trial to assess the effectiveness and cost-effectiveness of an m-health intervention to decrease the consumption of discretionary foods packed in school lunchboxes: the 'SWAP IT' trialRachel Sutherland, Alison Brown, Nicole Nathan, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2011
Design driven HtL: The discovery and synthesis of new high efficacy β₂-agonistsMichael J Stocks, Lilian Alcaraz, Andrew Bailey, et al.
Pageof 6